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Consumption of Whole Grain and Legume Powder Reduces
Insulin Demand, Lipid Peroxidation, and Plasma
Homocysteine Concentrations in Patients
With Coronary Artery Disease
Randomized Controlled Clinical Trial
Yangsoo Jang, Jong Ho Lee, Oh Yoen Kim, Hyun Young Park, Sang Yun Lee
Abstract—Our objective was to evaluate whether isocaloric replacement of refined rice with whole grains and other plant
products as a form of powder reduces coronary artery disease (CAD) risk factors, such as insulin demand and lipid
peroxidation in CAD patients. Seventy-six male patients with CAD were randomly assigned to either a group ingesting
a whole-grain meal daily or a control group for 16 weeks. In the whole-grain group, serum concentrations of glucose
and insulin decreased by 24% and 14%, respectively, without altering body weight and energy intake, whereas daily
intakes of fiber and vitamin E increased by 25% and 41%, respectively. Consumption of whole grains and legume
powder in CAD patients without diabetes decreased fasting levels of glucose and insulin. The areas under the curve for
insulin and glucose during the oral glucose tolerance test were also decreased. CAD patients with diabetes in the
whole-grain group also showed reductions in fasting glucose and in the area under the curve for glucose. In the
whole-grain group, plasma malondialdehyde and homocysteine and urinary 8-epi-prostaglandin F2 concentrations
decreased by 28%. Also, lipid-corrected concentrations of -carotene, retinol, tocopherols, and lycopene increased by
11% to 40%, and the percentage composition of n-6 fatty acids of serum phospholipid increased by 14% in the
whole-grain group. The replacement of refined rice with whole grain and legume powder as a source of carbohydrate
in a meal showed significant beneficial effects on glucose, insulin, and homocysteine concentrations and lipid
peroxidation in CAD patients. These effects are likely to substantially reduce the risk factors for CAD and diabetes.
(Arterioscler Thromb Vasc Biol. 2001;21:2065-2071.)
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Hyperinsulinemia, insulin resistance, and abdominal obe-sity frequently occur in patients with coronary artery
disease (CAD). Hyperinsulinemia, a manifestation of insulin
resistance, plays a significant role in the development and
progression of diabetes.1 Increased consumption of whole
grains has been recommended to improve insulin sensitivity
and to lower serum insulin concentrations.2,3 However, most
grain products consumed in developed countries are highly
refined.4 Refined grains are nutritionally inferior to whole
grains because they contain lower amounts of fiber, minerals,
vitamins, phenols, phytoestrogens, and unsaturated fatty
acids.3
Higher intake of many constituents of whole grains,
including dietary fiber, vitamin E, and polyunsaturated fatty
acids, has been independently associated with reduced risk of
CAD.2,5 In addition to reduced insulin resistance, the benefi-
cial effects of whole-grain consumption on lipid peroxidation
through antioxidative action may be another possible expla-
nation in the significant inverse relation of whole-grain intake
to the risk of CAD. Furthermore, recent reports of an
association between insulin resistance and hyperhomocys-
teinemia may suggest that whole-grain consumption de-
creased plasma homocysteine (Hcy).6,7 A review of epidemi-
ological literature found a clear inverse association between
whole-grain intake and the risk of ischemic heart disease
death.4 However, surprisingly, only a few prospective studies,
such as the Nurses’ Health Study, which showed that in-
creased intake of whole grains might protect against cardio-
vascular disease (CVD)5 and the research showing that higher
intake of whole grain foods was associated with a lower risk
of ischemic stroke among women,8 have examined whether
intake of whole grain decreased chronic disease risk.
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In addition to whole grains, other plant products, such as
vegetables and legumes, also have various kinds of phyto-
chemicals and antioxidants. A higher intake of fruits and
vegetables has been found to be protective against CVD, and
an increase in their intake has been emphasized.9 Two
hundred fifty observational studies on cancer and CVD have
also shown that the increasing consumption of fruits and
vegetables carries a large public health benefit.10 In a ran-
domized cross-design study, phytochemicals in soybeans
were found to reduce lipid peroxidation in vivo and to
increase the resistance of LDL to oxidation.11 Therefore, to
test the hypothesis that a higher intake of whole grain with
vegetables and legumes reduces diabetes and cardiovascular
risk factors in CAD patients, we specifically examined the
effect of the isocaloric replacement of refined rice (220 kcal)
with whole grain and legume powder (66.6% whole grains,
22.2% legumes, 5.6% seeds, and 5.6% vegetables) in CAD
patients.
Methods
Subjects and Study Design
Seventy-eight male patients with CAD were referred by the Division
of Cardiology of Yonsei Cardiovascular Center, Yonsei Severance
Hospital, Seoul, Korea. About a month before the start of the study,
they were all recruited concomitantly from participants in a prospec-
tive human genetic study, supported by The Brain Korea 21 Project
and R&D Promotion Center, Ministry of Health and Welfare, and
they all met the inclusion criteria according to the latest laboratory
data. The inclusion criteria required angiographic evidence with
50% occlusion of 1 major coronary artery, old myocardial
infarction, or angina pectoris, but any possible nonatherogenic
occlusions, such as osteal stenosis and spasm, were excluded.
Subjects with baseline lipid profiles with LDL cholesterol levels
3.36 mmol/L or triglyceride levels 1.81 mmol/L or total choles-
terol levels 5.17 mmol/L were selected. For patients taking
cholesterol-lowering medications, those with total cholesterol
3.88 mmol/L were included. All subjects were of stable weight for
1 year before the study. The macronutrient composition of each
subject’s usual diet was that of a typical diet with cooked refined
rice, which is consumed by a substantial number of Koreans; this diet
derives about 64% of energy from carbohydrates, 19% from fat, and
17% from protein. Of the CAD subjects, those with a diagnosis of
diabetes, renal disease, liver disease, or thyroid disease were ex-
cluded. Subjects on vitamin supplements were also excluded. All
subjects were outpatients; they underwent a clinical examination and
interview and gave their written informed consent to participate in
the study, which was approved by the Medical Ethics Committee of
Yonsei Medical University.
The present study was carried out in 2 phases: a 4-week run-in
phase consisting of the usual diet with cooked refined rice and a
16-week intervention phase consisting of the usual diet or consump-
tion of whole grain and legume powder. During the run-in period, 2
subjects, having maintained neither energy intake nor1% variation
in mean body weight, dropped out. The remaining 76 were randomly
subdivided into 2 groups and were assigned to consume either their
usual diet (cooked refined rice) or the whole grain and legume
powder for breakfast during the 16-week intervention.
Dietary Education and Nutrient Composition of
Whole Grain and Legume Powder
All subjects were given written and verbal instructions by a dietitian
on how to complete 3-day (2 weekdays and 1 weekend) dietary
records every 2 weeks throughout the whole study period. On the
sheet, subjects were instructed to record the amount of foods before
ingestion and any remaining after ingestion by weighing the foods.
During the 4-week run-in period, all participants were advised to
continue their usual diet of cooked refined rice. Baseline measure-
ments were also performed at the start of the run-in phase. After the
run-in period, the subjects in the control group maintained their usual
diet of cooked refined rice, and the subjects in the whole-grain group
consumed 70 g of whole grain and legume powder, replacing cooked
refined rice as a carbohydrate source for breakfast for 16 weeks. All
subjects in the whole-grain group consumed this powder by dissolv-
ing it in a glass of water. To check participants’ compliance during
the whole study period, the dietitian interviewed them during weekly
visits. They were interviewed to discern whether they were following
the program well, including dietary intake and weight changes.
During the study period, all participants were also encouraged to
maintain their usual lifestyle and were reminded not to make any
changes to their usual dietary habits, except for the whole-grain
powder substitution in whole-grain group.
Whole grains and legume powder were composed of 66.6% whole
grains, 22.2% legumes, 5.6% seeds, and 5.6% vegetables. The diet
consisted of brown rice (22.2%), glutinous brown rice (11.1%),
barley (22.2%), black beans (22.2%), sesame (5.6%), and Job’s tears
(11.1%), which were all roasted and coarsely ground. Little amounts
of pumpkin, onion, kale, crown daisy, chestnuts, dried sea mustard,
and mushroom were also added to the powder. These were added not
only for a coloring effect but also for enrichment of phytochemicals
and antioxidants. This was in response to consumers’ concerns about
their health. When compared with 150 g of cooked refined rice, 70 g
of whole grain and legume powder was as isocaloric as 220 kcal, but
it contained a different composition of nutrients. Cooked refined rice
(150 g) provided 46.6 g carbohydrate, 3.8 g protein, 0.73 g fat, 0.15 g
fiber, 0.42 mg vitamin E, 0.05 mg vitamin B1, 0.02 mg vitamin B2,
0.5 mg niacin, 0.09 mg vitamin B6, 4.62 g folate, 0.63 g saturated
fatty acid, 0.84 g monounsaturated fatty acid, and 0.90 g polyunsat-
urated fatty acid, whereas 70 g of whole grain and legume powder
provided 35.6 g carbohydrate, 9.2 g protein, 5.0 g fat, 4.2 g fiber,
28.4 retinol equivalent vitamin A, 41.0 g -carotene, 0.62 mg
vitamin E, 0.2 mg vitamin B1, 0.1 mg vitamin B2, 2.0 mg niacin, 0.6
mg vitamin B6, 7.1 g folate, 0.76 g saturated fatty acid, 1.27 g
monounsaturated fatty acid, and 2.39 g polyunsaturated fatty acid.
Nutrient intake data were calculated as mean values from a 3-day
food record with use of the database of the computerized Korean
food code, which is based on food composition tables for the year
2000 by the National Rural Living Science Institute in Korea. For
more information about usual intake, a semiquantitative food fre-
quency questionnaire was used together with a 3-day dietary record.
BMI, Blood Collection, Blood Pressure
Measurement, and Lipid Profile
Body mass index (BMI) was calculated as weight (in kilograms)
divided by height (in meters squared). Venous blood specimens were
collected after a 12-hour fast in EDTA-treated or plain tubes. The
tubes were immediately covered with aluminum foil and placed on
ice in the dark until they arrived at the laboratory room. Blood
pressure was read from the left arm while the subjects remained
seated. An average of 3 measurements was recorded for each subject.
The fasting total serum cholesterol and serum triglyceride levels
were measured enzymatically, and the HDL cholesterol fraction was
measured after precipitation of LDL and VLDL with dextran
sulfate–magnesium. LDL cholesterol was estimated indirectly by
using the Friedewald formula, ie, LDLtotal cholester-
ol[HDL(triglycerides/5)], for subjects with serum triglyceride
levels 4.52 mmol/L.
OGTT and HOMA
Subjects received a 75 g glucose solution after an overnight fast to
investigate the effect of whole grain and legume powder on glucose
and insulin responses. Venous specimens were collected before and
30, 60, 90, and 120 minutes after loading. The glucose criteria, newly
developed and modified by the National Diabetes Data Group and
the World Health Organization Expert Committee on Diabetes
Mellitus, were used to categorize subjects as diabetic: symptoms
with a casual plasma glucose 11.1 mmol/L or fasting glucose
7.0 mmol/L and oral glucose tolerance test (OGTT) with a 2-hour
postload value 11.1 mmol/L.12 Glucose was measured by a glucose
oxidase method with use of the Beckman Glucose Analyzer (Beck-
man Instruments). Insulin was measured by radioimmunoassays with
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commercial kits from Immuno Nucleo Corp. Each response of
glucose and insulin was calculated with the area under each response
curve. Insulin resistance and -cell function were also calculated
with the homeostasis model assessment (HOMA).13 The formulas
are as follows: insulin resistance[fasting insulin (U/mL)fasting
glucose (mmol/L)]/22.5, and -cell function20fasting insulin
(U/mL)/[fasting glucose (mmol/L)3.5].
Plasma Total Hcy and Serum Retinol,
Carotenoids, and Tocopherols
Plasma total Hcy was analyzed with a Bio20 Autoloader Amino Acid
Analyzer (Pharmacia Biotech), including a postcolumn ninhydrin
reaction system according to the modified method of Anderson,
Ueland, and colleagues.14,15 Reversed-phase high-performance liq-
uid chromatography (HPLC) was used to determine retinol, carote-
noids, and tocopherols in serum simultaneously, as described by
Yeum et al,16 Vogel et al,17 and Fotouchi et al.18 The HPLC system
consisted of an Alliance Waters 2690 separation module, Waters 996
photodiode array detector, Waters 474 scanning fluorescence detec-
tor, C18 Symmetry 3.915-cm column, and PDA Millennium for
version 2.15 data station (Waters). The Waters 474 scanning fluo-
rescence detector was set at 294 nm for the detection of tocopherols.
Levels of retinol, carotenoids, and tocopherols in serum were
reported as corrected levels and expressed as the sum of the serum
lipid (in millimoles per liter).19
Plasma Malondialdehyde and Folate
Plasma malondialdehyde (MDA) was assayed according to the
fluorometric method described by Buckingham.20 Plasma folate
level was analyzed with the kit from Immuno Nucleo Corp
Pharmaceuticals.21
Urine Collection and 8-Epi-PGF2
Urine was collected after a 12-hour fast in polyethylene bottles
containing 1% butylated hydroxytoluene before blood collection.
The tubes were immediately covered with aluminum foil and stored
at 70°C until extraction. Urinary 8-epi-prostaglandin F2 (8-epi-
PGF2) was quantified with gas chromatography (Hewlett Packard
6890) and mass selective detector (Hewlett Packard 3973), according
to the modified method of Pratico et al22 and Mori et al.23 For gas
chromatography/mass spectrometry, pentafluorobenzyl derivatives,
as opposed to the pentafluorobenzyl ester, were used; after which,
trimethylsilyl derivative, as opposed to bis-trimethylsilyl ester, was
used. The gas chromatography/mass spectrometry was programmed
to go from 190°C to 310°C at 10°C/min; retention time was 8.5
minutes. Quantification of 8-epi-PGF2 was performed by using the
peak area ratio. Urinary creatinines were determined by the alkaline
picrate (Jaffe) reaction,24 and urinary 8-epi-PGF2 levels were
expressed as picomoles per millimole creatinine.
Serum Phospholipid Fatty Acid Composition
Serum phospholipid composition was analyzed with the modified
method of Folch et al,25 with the use of gas chromatography (Hewlett
Packard 6890). The temperatures of injection and detector ports were
set at 280°C/min, and retention time was 40 minutes. A flame
ionization detector was used, and helium was used as the carrier gas
at 0.7 mL/min. Peaks were identified by comparison with a known
standard mixture (Supelco). Individual fatty acids were calculated as
a relative percentage with the elevated fatty acids set at 100% with
Chemstation software. Total n-3 (18:3 n-3, 20:3 n-3, 20:5 n-3, 22:5
n-3, and 22:6 n-3) and n-6 (18:2 n-6, 18:3 n-6, 20:3 n-6, 20:4 n-6,
22:4 n-6, and 22:5 n-6) fatty acids were measured in plasma
phospholipids.
Statistical Analysis
Statistical analysis was performed with Win SPSS (Statistical Pack-
age for the Social Science, SPSS Inc). For descriptive purposes,
mean values were presented on untransformed and unadjusted
variables. Results were expressed as meanSE. Effects of the diet on
end points were tested by a paired t test in each group before and
after consumption. According to whether the subject turns out to
have new-onset diabetes, fasting levels of glucose and insulin, their
response areas, and insulin resistances were tested by using the
Wilcoxon signed rank sum test in each group or by using the
Wilcoxon rank sum test between the 2 groups. To determine a more
accurate effect of whole grain and legume powder, net differences
(change in whole-grain group versus change in control group) were
evaluated. To compare differences in frequencies, 2 tests were used.
A value of P0.05 was considered statistically significant.
Results
Basic Characteristics at Start of
16-Week Intervention
After the run-in period, of 78 subjects, only 76, who had
maintained their energy intake and had 1% variation in
mean body weight, were selected to participate in the inter-
vention program and were randomly subdivided into the
control group or the whole-grain group. There were no
significant differences in baseline characteristics, such as age,
BMI, lipid profile, medications, and education level between
the 2 groups at the start of the 16-week intervention (Table 1).
Dosages of antihypertensive and lipid-lowering drugs were
not changed during the intervention period.
Body Weight, Energy and Nutrient Intake, and
Lipid Profile
There was 1% variation in mean body weight between
week 0 and 16 in the 2 groups that maintained their usual
energy intake. Frequent interviews with the subjects did not
suggest any important changes in the physical activity pat-
terns of the individual subjects during the study. As expected,
BMI and total energy intake were similar before and after
treatment in both groups. However, diastolic blood pressure
decreased and energy percentage of protein intake increased
significantly in the whole-grain group (Tables 1 and 2).
Concentration of HDL cholesterol increased significantly in
the whole-grain group. However, there were no significant
differences in other lipid profiles (Table 1). With the substi-
tution of whole grain and legume powder for refined rice,
estimates of fiber and vitamin E intake increased significantly
(Table 2). Compared with net differences of these parameters,
percent energy intake of protein, vitamin E intake, and HDL
cholesterol level in the whole-grain group showed significant
increases. However, percent energy intake of carbohydrate
significantly decreased in this group. There were no signifi-
cant differences in net differences of the other parameters.
Glucose and Insulin
Glucose and insulin concentrations of the control group did
not change significantly between 0 and 16 weeks, whereas
serum glucose concentrations of the whole-grain group sig-
nificantly decreased (Table 2). To investigate the effect of
whole-grain powder on glucose and insulin response, OGTT
was examined, and 9 of the subjects in the control group and
12 of the subjects in the whole-grain group were found to
have new-onset diabetes. However, there was no significant
difference in diabetic proportion between the 2 groups.
The effects of whole-grain and legume consumption on
serum concentrations of insulin and glucose are shown in
Table 3. All subjects were subdivided into 2 categories:
nondiabetic subjects and subjects with new-onset diabetes
according to OGTT. In the nondiabetic category, the whole-
grain group showed significant decreases in fasting glucose
level, response areas of glucose and insulin, and insulin
Jang et al Whole Grain Powder and CV Risk Factors in CAD 2067
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resistances and a significant increase in the percentage of -cell
function from the HOMA equation compared with the values in
the control group. Net differences of these values also showed a
similar pattern with results above. In the group with new-onset
diabetes, the fasting level and response area of glucose in the
whole-grain group significantly decreased, and net differences of
these values also showed significance (Table 3).
MDA, 8-Epi-PGF2, Total Hcy, Vitamins,
and Carotenoids
Plasma MDA and urinary 8-epi-PGF2 concentrations de-
creased by 28% in the whole-grain group, but there was no
significant change in the control group (Table 4). With
whole-grain and legume consumption, plasma Hcy concen-
tration decreased by 32%, and unlike the usual case, plasma
folate concentration merely showed a tendency to decrease.
Net differences of these values also showed significant
decreases in the whole-grain group.
Lipid-corrected concentrations of -carotene, retinol, -to-
copherol, -tocopherol, and lycopene increased by 11% to
40% in the whole-grain group but did not change signifi-
cantly in the control group (Table 4). Lipid-corrected con-
centrations of -carotene and cryptoxanthin did not change
significantly in either group. Only in the case of retinol and
-carotene did net differences show a significant increase in
the whole-grain group.
Serum Phospholipid Fatty Acids
The fatty composition of serum phospholipids at baseline was
not significantly different between the 2 groups (Table 4). In
TABLE 1. Baseline Characteristics, BMI, and Serum Lipid Profiles in CAD Male Patients
Control (n38) Whole Grain (n38)
0 wk 16 wk 0 wk 16 wk P *
Age, y 58.41.53    54.81.20      
Consumption of medication†, n 34    28      
Antihypertensive agent 15    12      
Lipid-lowering agent 20    26      
Education level†, n
University 18    12      
High school 9    12      
BMI, kg/m2 24.30.34 24.60.34 25.10.35 24.90.35 0.071
Triglycerides, mmol/L 1.740.20 1.660.14 1.840.17 1.630.13 0.158
Total cholesterol, mmol/L 5.250.13 5.230.13 4.910.12 4.820.13 0.343
LDL cholesterol, mmol/L 3.430.13 3.390.13 3.060.13 2.910.13 0.192
HDL cholesterol, mmol/L 1.110.03 1.100.04 1.030.04 1.190.06‡ 0.001
Values are meanSE. Age was tested by independent t test.
*Comparison of net differences between 2 groups.
†By 2 tests to compare differences in frequencies.
‡P0.001 compared with initial value in each group.
TABLE 2. Effects of Whole-Grain Consumption on Blood Pressure, Glucose, and Insulin Levels
and Estimates of Daily Nutrient Intakes in CAD Male Patients
Control (n38) Whole Grain (n38)
P *0 wk 16 wk 0 wk 16 wk
Systolic BP, mm Hg 131.22.01 129.72.56 131.82.81 129.12.73 0.722
Diastolic BP, mm Hg 82.21.52 81.91.04 85.21.24 81.31.12‡ 0.112
Glucose, mmol/L 4.710.22 4.900.24 6.230.19 4.730.17§ 0.000
Insulin, pmol/L 68.45.16 68.49.72 75.03.66 64.23.78‡ 0.195
Estimates of daily nutrient intakes†
Energy intake, kJ/d 8518237 8665268 9160210 9034139 0.328
Carbohydrate, % 68.31.02 69.30.95 64.21.63 61.01.38 0.032
Protein, % 15.30.40 14.80.40 17.30.71 19.40.51 0.001
Fat, % 16.10.82 15.90.75 18.61.29 19.51.11 0.455
Vitamin E, mg/d 11.11.89 9.20.91 6.730.82 9.480.92 0.034
Fiber, g/d 23.12.91 23.21.73 20.81.81 26.01.25 0.128
BP indicates blood pressure. Values are meanSE.
*Comparison of net differences between 2 groups.
†Nutrient intakes, obtained from weighed food records and calculated by using the database of the computerized
Korean food code.
‡P0.05, §P0.001, and P0.01 compared with the initial value in each group.
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the whole-grain group, the percent composition of n-6 fatty
acids of serum phospholipid increased significantly; however,
there was no significance in the net difference between the 2
groups.
Discussion
The isocaloric replacement of refined rice with whole-grain
powder resulted in substantial improvement in glucose and
insulin metabolism as well as reduction in lipid peroxidation
and plasma Hcy concentration in CAD patients. Current
dietary guidelines for CAD patients recommend increased
intake of whole-grain products, legumes, and vegetables, but
the amount that is to be consumed is not specified. The
present study shows that replacing refined grains with whole
grains and other plant products as a form of coarse powder in
1 meal for 16 weeks may reduce the risk factors for CAD and
diabetes.
Whole-grain products, because of their physical form and
high content of fiber, tend to be slowly digested and absorbed
and, thus, have relatively low glycemic indexes.5 In diabetic
and nondiabetic subjects, higher intakes of foods with a low
glycemic index have been reported to have an association
TABLE 3. Glucose and Insulin Responses on 75-g Oral Glucose Tolerance Test Between Control and Whole-Grain Group According to
Presence or Absence of Diabetes Identified During the Study
Nondiabetic CAD (n55) New-Onset Diabetic CAD (n21)
Control (n29) Whole Grain (n26)
P *
Control (n9) Whole Grain (n12)
P *0 wk 16 wk 0 wk 16 wk 0 wk 16 wk 0 wk 16 wk
Fasting level
Glucose, mmol/L 4.310.15 4.450.16 5.750.15 4.460.17† 0.000 6.060.62 6.320.68 7.290.38¶ 5.300.31§ 0.023
Insulin, pmol/L 64.85.52 58.25.70 78.64.44 66.04.50‡ 0.304 71.411.4 102.037.3 67.26.24 61.87.08 0.792
Response area
Glucose, (mmol/L)h 18.00.56 17.20.47 17.00.59 13.80.45† 0.000 26.81.52¶ 26.11.38 23.21.13¶ 17.91.18‡ 0.021
Insulin, (pmol/L)h 644.780.2 637.373.0 751.287.0 567.072.0§ 0.022 547.899.6 430.847.8 426.663.6 377.462.4 0.135
HOMA equation
-Cell function, % 217.2140.0 185.4151 137.518.8 333.642.8† 0.003 184.256.4 120.618.0 63.26.00¶ 140.018.5§ 0.135
Insulin resistance 2.050.19 1.870.17 3.440.21 2.160.17† 0.001 3.170.49 6.213.41 3.710.48 2.580.45 0.157
Values are meanSE.
*Comparison of net differences between 2 groups in either nondiabetic or diabetic CAD by the Wilcoxon rank sum test.
†P0.001, ‡P0.05, and §P0.01 compared with initial value in each group; P0.01 and ¶P0.001 compared with nondiabetic CAD in each group.
TABLE 4. Effects of Whole-Grain Consumption on Plasma MDA, Hcy, and Urinary 8-Epi-PGF2
Serum Vitamins and Carotenoids, and Fatty Acids of Serum Phospholipid in CAD Patients
Control (n38) Whole Grain (n38)
0 wk 16 wk 0 wk 16 wk P *
MDA, nmol/mL 3.330.25 3.260.31 4.650.32 3.460.29 0.028
8-Epi-PGF2 pmol/mmol creatinine 579.955.8 493.944.2 526.865.1 384.051.5¶ 0.003
Hcy, mol/L 12.91.03 12.01.21 12.80.53 8.750.44¶ 0.032
Folate, nmol/L 12.40.73 13.40.75 10.40.81 9.610.63 0.335
Lipid-corrected levels†
-Carotene, g/mmol 4.470.52 4.100.74 4.790.51 6.000.55 0.058
-Carotene, g/mmol 42.75.59 44.15.40 32.75.20 37.24.96 0.667
Retinol, g/mmol 205.415.1 204.621.9 190.115.7 229.117.7 0.008
-Tocopherol, g/mmol 0.500.04 0.490.04 0.490.05 0.680.05# 0.006
-Tocopherol, g/mmol 0.100.00 0.100.00 0.180.02 0.200.02 0.105
Cryptoxanthin, g/mmol 68.010.8 83.77.90 73.68.54 67.58.58 0.059
Lycopene, g/mmol 51.96.71 51.58.77 39.44.01 55.16.14 0.148
Serum phospholipid fatty acids
n-6‡, % of total fatty acids 19.50.97 19.61.06 18.10.61 20.70.77 0.083
n-3§, % of total fatty acids 5.220.39 4.780.22 5.800.38 5.770.34 0.523
Values are meanSE.
*Comparison of net differences between 2 groups.
†Each level of vitamins and carotenoids is divided by sum of cholesterol and triacylglyerol (mmol/L).
‡Sum of 182 n-6, 183 n-6, 203 n-6, 204 n-6, 224 n-6, and 225 n-6.
§Sum of 183 n-3, 203 n-3, 205 n-3, 225 n-3, and 226 n-3.
P0.01, ¶P0.001, and #P0.05 compared with initial value in each group.
Jang et al Whole Grain Powder and CV Risk Factors in CAD 2069
 at CONS KESLI on August 3, 2014http://atvb.ahajournals.org/Downloaded from 
with lower concentrations of insulin. Reduced insulin de-
mand, representing improvement of insulin sensitivity, may
be 1 of the protective mechanisms for CAD and diabetes in
association with a higher intake of whole grain.1,5 The present
study also shows that consumption of whole grain and
legume powder reduces insulin demand and hyperinsulinemia
in CAD patients with and without diabetes. In fact, an
epidemiological study reported that every 6-g increase in
daily fiber consumption was associated with a 25% reduction
in ischemic heart disease mortality.2 In addition, reduced risk
for CAD has been reported in people who consumed a diet
containing at least 37 g of dietary fiber per day.2
Whole-grain and legume consumption that decreases insu-
lin resistance or insulin demand, over a long term, may
reduce plasma Hcy concentration. This suggestion is related
to the report of an association between insulin resistance and
hyperhomocysteinemia.7 Recently, elevated total Hcy con-
centration, an independent risk factor for atherosclerosis,26
has also been suggested to be a possible biological link
between insulin resistance and atherothrombosis.6 Although
serum concentration of folate did not change significantly,
plasma Hcy concentration decreased in the whole-grain
group. It might be related to the improvement of insulin
resistance, according to decrease in fasting glucose and
decreased tendencies of fasting insulin and their respective
response.
In addition to being a good source of dietary fiber, whole
grains may have beneficial combinations of many micronu-
trients, antioxidants, and phytochemicals.4,5 Whole grains,
legumes, and vegetables are important dietary sources of
antioxidant vitamins and unsaturated fatty acids. The intake
of polyunsaturated fatty acids and vitamin E is associated
with protection from CAD, and carotenoids may also have
such protective effects.2 A tendency toward an increase in the
percent composition of n-6 fatty acids and in serum concen-
trations of lipid-corrected carotenoids, especially, -tocoph-
erol and retinol, in the whole-grain group of the present study
may result from an increased intake of these nutrients from
whole grains. In addition, other antioxidant intakes from
whole grain and legume powder and reduced oxidative stress,
such as decreased plasma Hcy concentration, could also spare
serum tocopherols and some carotenoids.
Whole grains, legumes, and vegetables contain many
antioxidants, including vitamins, trace minerals, and nonnu-
trients, such as phenolic acids, lignans, and phytoestrogens,
and antinutrients, such as phytic acid.4,9,13 Antioxidants in
whole grains can slow the rate of oxidation of oxidizable
substrates.3,4 Measurement of products of lipid peroxidation,
such as plasma MDA27 and urinary 8-epi-PGF2,28,29 may
offer a noninvasive approach to the assessment of oxidative
stress and the efficacy of antioxidant therapies. The decrease
of plasma MDA and urinary 8-epi-PGF2 concentrations in
the whole-grain group might be due to the antioxidative
effects of many antioxidants in whole grains and other plant
products. In addition, reduced plasma Hcy concentration in
the whole-grain group might contribute to the decrease in
lipid peroxidation. Recently, Voutilainen et al26 published a
study about an enhancement of in vivo lipid peroxidation at
elevated fasting plasma total Hcy concentration.
In summary, the present study showed significant benefi-
cial effects of consumption of whole grains and other plant
products as a form of coarse powder on glucose, insulin, and
Hcy concentrations and lipid peroxidation in CAD patients.
These effects are likely to substantially reduce the risk factors
of CAD and diabetes in CAD patients. The biological
mechanism, whereby whole grain and legume powder may
exert their protective effect is not clear in the present study,
but it is likely to be due to multiple mechanisms, such as
fiber, antioxidants, and many constituents of whole grain and
legume powder. Therefore, grains should be consumed in a
minimally refined form, and frequent consumption of vege-
tables and legumes should be recommended to reduce car-
diovascular risk factors and the incidence of diabetes in CAD
patients.
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